Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company
focused on the development and commercialization of innovative therapies
for diseases and conditions of the eye, today announced that Amar
Sawhney, Ph.D., President and Chief Executive Officer, will participate
in two upcoming conferences:
-
RBC Capital Markets Healthcare Conference
Tuesday, February 24,
2015 at 11:00 a.m. Eastern Time
The New York Palace Hotel, New
York, NY
-
Cowen and Company 35th Annual Health Care Conference
Wednesday,
March 4, 2015 at 10:40 a.m. Eastern Time
The Boston Marriott
Copley Place Hotel, Boston, MA
A live audio webcast of the presentations can be accessed through the
Calendar of Events section of the Company's website at investors.ocutx.com.
A replay of the webcasts will be available on the Company's website for
two weeks following the presentation.
About Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the
development and commercialization of innovative therapies for diseases
and conditions of the eye using its proprietary hydrogel platform
technology. Ocular Therapeutix's lead product candidates are in Phase 3
clinical development for post-surgical ocular inflammation and pain, and
Phase 2 clinical development for glaucoma, allergic conjunctivitis, and
dry eye disease. The Company is also evaluating sustained-release
injectable anti-VEGF drug depots for back-of-the-eye diseases. Ocular
Therapeutix's first product, ReSure® Sealant, is FDA-approved to seal
corneal incisions following cataract surgery.
Copyright Business Wire 2015